Dare Bioscience (DARE) Current Leases (2019 - 2026)
Dare Bioscience's (DARE) quarterly Current Leases came in at $1.5 million in Q4 2025, up 172.33% YoY from $548638.0 in Q4 2024, and up 145.25% on a QoQ basis from $609224.0 in Q3 2025.
Dare Bioscience (DARE) Current Leases (2019 - 2026) Analysis & Trends
Dare Bioscience (DARE) has 7 years of Current Leases data on file, last reported at $1.5 million in Q4 2025.
- Quarterly Current Leases rose 172.33% year-over-year to $1.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.5 million (up 172.33% YoY) and the FY2025 annual result came in at $1.5 million, up 172.33% from the prior year.
- Current Leases climbed to $1.5 million in Q4 2025, from $609224.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $1.8 million in Q2 2025 to a low of $195000.0 in Q3 2023.
- A 5-year average of $534669.9 and a median of $431473.0 in 2021 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2023 — Current Leases plunged 49.74% — and 2025, when it jumped 275.21%.
- Tracing DARE's Current Leases over 5 years: stood at $270546.0 in 2021, then soared by 47.25% to $398391.0 in 2022, then grew by 17.65% to $468726.0 in 2023, then advanced by 17.05% to $548638.0 in 2024, then surged by 172.33% to $1.5 million in 2025.
- The last three Current Leases figures came in at $1.5 million (Q4 2025), $609224.0 (Q3 2025), and $1.8 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.47 Bn | 131.61 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.36 Bn | 78.37 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.16 Bn | 59.98 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.99 Bn | 53.85 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.74 Bn | 28.43 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.01 Bn | 9.61 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | - |
| 10 | Dare Bioscience | 12.53 Mn | -89,288.95 | -132,343.00 | 594,493.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 594,493.00 |
| Dec 31, 2025 | 1.49 Mn |
| Sep 30, 2025 | 609,224.00 |
| Jun 30, 2025 | 1.83 Mn |
| Mar 31, 2025 | 568,297.00 |
| Dec 31, 2024 | 548,638.00 |
| Sep 30, 2024 | 505,824.00 |
| Jun 30, 2024 | 488,152.00 |
| Mar 31, 2024 | 470,390.00 |
| Dec 31, 2023 | 468,726.00 |
| Sep 30, 2023 | 195,000.00 |
| Jun 30, 2023 | 271,825.00 |
| Mar 31, 2023 | 335,764.00 |
| Dec 31, 2022 | 398,391.00 |
| Sep 30, 2022 | 388,000.00 |
| Jun 30, 2022 | 323,956.00 |
| Mar 31, 2022 | 294,000.00 |
| Dec 31, 2021 | 270,546.00 |
| Sep 30, 2021 | 368,000.00 |
| Jun 30, 2021 | 418,946.00 |